Prashant Gabani, MD (@prg266) 's Twitter Profile
Prashant Gabani, MD

@prg266

Baylor Scott and White Health, Department of Radiation Oncology

ID: 816687079749025792

calendar_today04-01-2017 16:45:47

148 Tweet

197 Followers

75 Following

WashU Medicine Radiation Oncology (@washumedradonc) 's Twitter Profile Photo

This Friday is #ThankaResidentDay....but we wanted to start early with messages of thanks from our dept! 📢 We will start from the TOP with a message from the Chair of @WashURadOnc, Dr. Dennis Hallahan. @Sperkins_radonc Allison Lehman Randall Brenneman

Prajnan Das, MD, MS, MPH (@prajnandasmd) 's Twitter Profile Photo

Adjuvant nivolumab doubles median DFS after preop chemoRT and surgery for esophageal and GEJ cancer. ILSON David calls this a new standard of care. nejm.org/doi/full/10.10…

Susana Banerjee (@banerjeesusana) 's Twitter Profile Photo

Landmark phase III results for women with recurrent cervical cancer presented #ESMOVirtualPlenary #cervicalcancer Cemiplimab 1st immunotherapy to extend overall survival ESMO - Eur. Oncology

Landmark phase III results for women with recurrent cervical cancer presented #ESMOVirtualPlenary #cervicalcancer Cemiplimab 1st immunotherapy to extend overall survival <a href="/myESMO/">ESMO - Eur. Oncology</a>
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

New ONLINE: CATNON, EORTC study 26053-22054 – Adjuvant and concurrent #temozolomide for 1p/19q non-co-deleted anaplastic #glioma: second interim analysis of a randomised, open-label, phase 3 study #btsm thelancet.com/journals/lanon…

Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

Beautiful scrollable atlas! Hey eContour - would it be cumbersome to digitize these into a case? Asking for a friend. Strong work!! #neuroonc #radonc

Dr Sarah Sammons (@drsarahsam) 's Twitter Profile Photo

The most interesting ASCO abstract I have read so far⭐️ CSF ctDNA in High risk stage III TNBC with pCR CSF ctDNA+ 126/323 (39%) 124/126 (98.4%) CSF ctDNA+ patients developed BrM! 2/197 CSF ctDNA- patients ➡️BrM (p < 0.001) I think we found a way to predict brain mets #bcsm

The most interesting ASCO abstract I have read so far⭐️

CSF ctDNA in High risk stage III TNBC with pCR

CSF ctDNA+ 126/323 (39%)

124/126 (98.4%) CSF ctDNA+ patients developed BrM! 

2/197 CSF ctDNA- patients ➡️BrM (p &lt; 0.001)

I think we found a way to predict brain mets #bcsm
Shauna Campbell, DO (@shaunaradonc) 's Twitter Profile Photo

Well here you go #radonc friends➡️ management of the axilla by our #CleClinicCancer #BCSM expert Chirag Shah. Clear & concise summary of decision making 👍.

Prashant Gabani, MD (@prg266) 's Twitter Profile Photo

I use 5 fx whole breast +/- single fx boost for some early stage breast cancer. EviCore By Evernorth and Cigna Healthcare rejected my prior authorization request for the single fraction boost! Would you rather me use the more expensive 16 fx whole breast and 5 fx boost? ASTRO #Fixpriorauth

Radiation Nation (@rad_nation) 's Twitter Profile Photo

We're discussing fractionation for #BreastCancer treatment for the Global #RadOnc #JC radonc.radiationnation.com/ultrahypofract… Live Hour @ 2pm EST x.com/i/spaces/1BdxY… What is your standard? c Majid Al Othman Luis Moreno Sánchez Marisa C. Weiss, M.D. Peppe Sasso Rajiv Dave Imo 🇪🇺⭐️ Locke 💙 @Boffersen Prashant Gabani, MD

Prashant Gabani, MD (@prg266) 's Twitter Profile Photo

I am hiring a remote dosimetrist. Please reach out if you are interested. Allows the flexibility of working from home. #radonc linkedin.com/posts/prashant…